巴奥胡酸I通过向转录的葡萄球菌附属调节因子SarZ来抑制多药耐药性黄金葡萄球菌的毒性
Zewen Wen1, Chengchun Chen1, Yongpeng Shang1
1Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Huazhong University of Science and Technology Union Shenzhen Hospital, No. 89 Taoyuan Road, Nanshan District, Shenzhen 518052, China.
概括
巴奥胡酸I通过向调节器SarZ.I来抑制黄金葡萄球菌生物膜的形成和毒性. 这种天然化合物在对抗持续性黄金色杆菌感染方面表现有前途.
科学领域:
- 微生物学 微生物学
- 自然产品化学 自然产品化学
- 药物发现 药物发现 药物发现
背景情况:
- 黄金葡萄球菌 (Staphylococcus aureus) 是一个重要的人类病原体,生物膜有助于持续性感染.
- 化物I,一种天然的黄醇糖化物,具有各种与健康相关的活动.
- 巴奥胡酸I对黄金菌的抗生物膜和抗病毒性潜力仍未得到充分研究.
研究的目的:
- 调查宝胡酸I的抗菌和抗生物膜特性,以对抗黄金菌.
- 阐明化物I对S. aureus生物膜形成和血溶性活动的作用的潜在分子机制.
- 通过使用Galleria mellonella感染模型评估Baohuoside I体内疗效.
主要方法:
- 在体外测试中评估了生物膜形成和毒性因素.
- 在体内疗效在Galleria mellonella模型中进行了测试.
- 使用药物亲和度响应目标稳定性 (DARTS),分子对接,EMSA,BLI和局部导向突变发生的机制被探索.
主要成果:
- 宝化物I显著抑制了S. aureus生物膜的形成和6.25μM的溶血活性.
- 蛋白质学和DARTS确定了Staphylococcus辅助调节因子 (SarZ) 作为Baohuoside I的直接目标.
- 化物I直接与SarZ结合,抑制其调节功能和下游毒性基因表达,Tyr27和Phe117残留物对结合至关重要.
- 萨尔兹淘汰菌株的血液溶解能力降低,证实了它在金黄色细菌毒性中的作用.
- 在G. mellonella的体内研究表明了Baohuoside I的有效性.
结论:
- 巴奥胡酸I通过向关键调节器SarZ,有效地抑制金黄色细菌的毒性.
- 化I和SarZ之间的相互作用为对抗金黄色菌感染提供了一种新的机制.
- 萨尔兹代表了一种有前途的治疗标,用于对抗黄金色杆菌的抗病毒性策略.
相关概念视频
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


